EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations

Hyunji Lim iD, Se Ik Kim iD, Kyung-Jin Min iD, Jae-Kwan Lee iD, Jae-Weon Kim iD, Taek Sang Lee iD

Journal of Gynecologic Oncology · 2026

DOI: 10.3802/jgo.2026.37.e71 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Hyunji Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Human Papillomavirus Viruses, Papillomavirus Infections, Papillomavirus Vaccines, Uterine Cervical Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Korean Society of Gynecologic Oncology (KSGO) first developed clinical guidelines for the appropriate administration of human papillomavirus (HPV) vaccines tailored to the Korean context in 2016. In 2019, additional guidelines were introduced following the development of the nonavalent HPV vaccine. The 2021 revision included recommendations for vaccination in middle-aged women and men, as well as the potential benefits of vaccination following conization. In this latest revision, the guidelines focus on the necessity of HPV vaccination in middle-aged men, the Society's position on the single-dose schedule recently recommended by the World Health Organization to expand global vaccine coverage, recommendations regarding additional 9-valent vaccination for those previously vaccinated with bivalent or quadrivalent vaccines, and updated scientific evidence supporting the two-dose schedule for adolescents aged 9 to 14 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Papillomavirus VirusesPapillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsVaccinationAdolescentChildFemaleHumansMaleImmunization ScheduleRepublic of KoreaSocieties, Medical

Stichwörter der Autor:innen

Cervical CancerCervical Intraepithelial NeoplasiaHuman PapillomavirusPreventionVaccination

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
  • Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea. tslee70@gmail.com.

ORCID-Profile: Hyunji Lim, Se Ik Kim, Kyung-Jin Min, Jae-Kwan Lee, Jae-Weon Kim, Taek Sang Lee

Zitieren

APA

Lim, H., Kim, S. I., Min, K. J., Lee, J. K., Kim, J. W., & Lee, T. S. (2026). Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e71

Vancouver

Lim H, Kim SI, Min KJ, Lee JK, Kim JW, Lee TS. Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e71

BibTeX
@article{Lim2026,
  author = {Lim, Hyunji and Kim, Se Ik and Min, Kyung-Jin and Lee, Jae-Kwan and Kim, Jae-Weon and Lee, Taek Sang},
  title = {Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations},
  journal = {Journal of Gynecologic Oncology},
  year = {2026},
  doi = {10.3802/jgo.2026.37.e71}
}
Kostenlos starten →